Live Breaking News & Updates on Global Hematopoietic Stem Cell Transplantation

Stay updated with breaking news from Global hematopoietic stem cell transplantation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Hematopoietic Stem Cell Transplantation (HSCT) Market Size Worth US$ 3.5 Bn By 2027 At A CAGR Of 11.3%


Hematopoietic Stem Cell Transplantation (HSCT) Market Size Worth US$ 3.5 Bn By 2027 At A CAGR Of 11.3%
iCrowd Newswire
07 May 2021, 03:40 GMT+10
Hematopoietic stem cell transplantation (HSCT) is likely to expand rapidly due to the rising geriatric population coupled with increase in success rates of transplantation and increasing demand for high-quality healthcare services. With the increasing prevalence of hematopoietic disorders across the globe, individuals are opting for better products. Hematopoietic stem cells are also known as hematopoietic progenitor cells (HPCs), present in the bone marrow and blood. Hematopoietic stem cells can quickly produce mature blood cells, such as red blood cells, white blood cells, and platelets. These mature cells are helpful in the treatment of different types of malignant and non-malignant diseases, such as lymphoma, leukemia, hemoglobinopathies, and bone marrow failure. These cells further rebuild or replace a patient s hematopoie ....

United States , Anishi Sharma , Cellgenix Gmb , Kiadis Pharma , Regen Biopharma Inc , Talaris Therapeutics Inc , Lonza Group , Stempeutics Research Pvt Ltd , Takeda Pharmaceutical Company , Taiga Biotechnologies Inc , Research Newswire , See Campaign , Therapeutics Inc , Marker Therapeutics Inc , Pluristem Therapeutics Inc , Global Hematopoietic Stem Cell Transplantation , Transplant Type Outlook , Indication Outlook , Acute Myeloid Leukemia , Acute Lymphoblastic Leukemia , Non Hodgkin Lymphoma , Multiple Myeloma , Application Outlook , Bone Marrow Transplant , Peripheral Blood Stem Cells Transplant , Cord Blood Transplant ,